Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.



J. David Gladstone Institutes

Award Total: $7,975,380 # of Grants: 20
Investigators

RobertPitasPh.D. - RobertPitasPh.D. - RobertPitasPh.D. - RobertPitasPh.D. - RobertPitasPh.D. - IsraelCharoM.D., Ph.D. - ThomasInnerarityPh.D. - ThomasInnerarityPh.D. - BeatrizLevy-WilsonPh.D. - MartinHersbergerPh.D. - YadongHuangM.D., Ph.D. - StephenYoungM.D. - StephenYoungM.D. - DavidDichekM.D. - Murielle MarieVeniantPh.D. - JohanBjorkegrenM.D., Ph.D. - MartinBergoM.D., Ph.D. - MartinBergoM.D., Ph.D. - RobertRaffaiPh.D. - UgurHodoglugilM.D., Ph.D. - KimberlyCordesPh.D. - NathalieGaboritPh.D. - SwetansuHotaPh.D -
Grants

Cloning & Expression of the Apo-B mRNA Editing Factor 1994 (Cycle 3) $254,743
Cardiovascular Disease Research Project Awards

Proteins that Remove Atherogeneic Lipoproteins from Blood 1995 (Cycle 4) $678,254
Cardiovascular Disease Research Project Awards

Expression of the Human apo-B Gene in Transgenic Mice 1995 (Cycle 4) $211,090
Cardiovascular Disease Research Project Awards

How are beneficial cholesterol transport proteins produced? 1998 (Cycle 7) $37,069
Cardiovascular Disease Postdoctoral Fellowship Awards

How does cardiac fuel metabolism influence heart disease? 1998 (Cycle 7) $262,005
Cardiovascular Disease New Investigator Awards

Will ApoE cause regression of atherosclerotic lesions? 1998 (Cycle 7) $165,299
Cardiovascular Disease Research Project Awards

Towards gene therapy for tobacco-related vascular disease 1998 (Cycle 7) $719,328
Cardiovascular Disease Research Project Awards

Determining how cholesterol-rich Lp(a) causes heart disease 1998 (Cycle 7) $797,092
Cardiovascular Disease Research Project Awards

Lipoprotein classes and susceptibility to atherosclerosis 1998 (Cycle 7) $702,940
Cardiovascular Disease Research Project Awards

Role of the Acetyl LDL Receptor in Atherogenesis 1994 (Cycle 3) $121,187
Cardiovascular Disease Research Project Awards

Monocyte Chemoattractant Protein (MCP-1) in Atherosclerosis 1994 (Cycle 3) $484,207
Cardiovascular Disease Research Project Awards

Importance of Rce1 and Ras in tobacco-induced cancers 1999 (Cycle 8) $75,209
Cancer Postdoctoral Fellowship Awards

A model system for smoking-related damage to proteins 1999 (Cycle 8) $75,375
Cardiovascular Disease Postdoctoral Fellowship Awards

Apolipoprotein E: remnant metabolism and atherogenesis 1999 (Cycle 8) $793,474
Cardiovascular Disease Research Project Awards

Post-isoprenylation processing steps as anticancer targets 2000 (Cycle 9) $1,017,450
Cancer Research Project Awards

ApoE isoforms, fatty acid metabolism and atherosclerosis 2001 (Cycle 10) $691,616
Cardiovascular Disease Research Project Awards

Remnant lipoproteins, apolipoprotein E4 and atherosclerosis 2001 (Cycle 10) $400,500
Cardiovascular Disease New Investigator Awards

Enzymatic targets for anticancer therapy 2002 (Cycle 11) $267,304
Cancer New Investigator Awards

Triglyceride metabolism: Genetics, smoking and heart disease 2003 (Cycle 12) $75,438
Cardiovascular Disease Postdoctoral Fellowship Awards

Chromatin remodellers Brg1 and Baf60c in heart development 2013 (Cycle 22) $145,800
Early Diagnosis/Pathogenesis Postdoctoral Fellowship Awards